GeneWerk GmbH (private company)
See something wrong or missing? Let us know
Offices:Heidelberg
Industry:BiotechHealth services
Business model:B2B
GeneWerk GmbH provides highly sensitive platforms and bioinformatics to determine fusion sequences adjacent to known DNA or RNA fragments in minimal tissue samples down to the single cell level.
Applications include clonality and safety of (viral) vectors in gene therapy, on-target specificity of designer nucleases, immune repertoire studies in T cells and B cells and next generation sequencing (NGS).
Investors:
we tracked 1 investor
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to GeneWerk GmbH
| Name | Criteria | |
|---|---|---|
 |
AbolerIS Pharma
37%
|
|
 |
Abzena
37%
|
|
|
Achilles Therapeutics
37%
|
|
 |
Adrenomed AG
37%
|
|
 |
AFYX Therapeutics
37%
|
|
 |
Algenex
37%
|
|
 |
Alvotech
37%
|
|
|
Antag Therapeutics
37%
|
|
 |
Antelope Dx
37%
|
|
 |
APIM Therapeutics
37%
|
|
Netherlands
Austria
Switzerland
Estonia
Finland
Latvia
Lithuania
Sweden
Ireland
Italy
Portugal